Select Publications
Journal articles
2019, 'Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study', Journal of Clinical Lipidology, 13, pp. 148 - 155, http://dx.doi.org/10.1016/j.jacl.2018.08.014
,2017, 'Long-term survival following the development of heart failure in an elderly hypertensive population', Cardiovascular Therapeutics, 35, http://dx.doi.org/10.1111/1755-5922.12303
,2015, 'Rate of change in renal function and mortality in elderly treated hypertensive patients', Clinical Journal of the American Society of Nephrology, 10, pp. 1154 - 1161, http://dx.doi.org/10.2215/CJN.07370714
,2014, 'A journal's progress', Internal Medicine Journal, 44, pp. 441 - 442, http://dx.doi.org/10.1111/imj.12423
,2008, 'Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives', Hypertension, 51, pp. 1129 - 1134, http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.106310
,2007, 'Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial', Hypertension, 49, pp. 1242 - 1247, http://dx.doi.org/10.1161/HYPERTENSIONAHA.106.085803
,2006, 'Gifts, Drug Samples, and other Items Given to Medical Specialists by Pharmaceutical Companies', Journal of Bioethical Inquiry, 3, pp. 139 - 148, http://dx.doi.org/10.1007/s11673-006-9019-0
,2006, 'Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives', Hypertension, 47, pp. 785 - 790, http://dx.doi.org/10.1161/01.HYP.0000209340.33592.50
,2006, 'Mechanics or mediators: Arterial damage from high blood pressure', Journal of Hypertension, 24, pp. 1921 - 1923, http://dx.doi.org/10.1097/01.hjh.0000244937.26922.f9
,2006, 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia', Internal Medicine Journal, 26, pp. 571 - 578
,2005, 'Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the aged', American Journal of Hypertension, 18, pp. 885 - 888, http://dx.doi.org/10.1016/j.amjhyper.2004.12.018
,2005, 'On not becoming a writer ...', Internal medicine journal, 35, pp. 197, http://dx.doi.org/10.1111/j.1445-5994.2005.00770.x
,2005, 'Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations', Internal Medicine Journal, 35, pp. 206 - 210
,2005, 'Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience', Medical Journal of Australia, 182, pp. 557 - 560
,2005, 'Who`s really hypertensive? - Quality control issues in the assessment of blood pressure for randomized trials', Blood Pressure, 14, pp. 133 - 138
,2003, 'A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly', New England Journal of Medicine, 348, pp. 583 - 592, http://dx.doi.org/10.1056/NEJMoa021716
,2002, 'Considerations for the safe prescribing and use of COX-2-specific inhibitors', Medical Journal of Australia, 176, pp. 328 - 331
,2000, 'Effects of nitric oxide synthase inhibition on Angiotensin receptors and metabolism in the pregnant hypertensive rat.', Clinical Science, 100, pp. 319 - 328
,1999, 'Helicobacter pylori and peptic ulcer disease [1] (multiple letters)', Australian and New Zealand Journal of Medicine, 29, pp. 271, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00696.x
,1999, 'The Journal in 1998: Editorial', Australian and New Zealand Journal of Medicine, 29, pp. 1, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01579.x
,1999, 'The next beginning', Australian and New Zealand Journal of Medicine, 29, pp. 654, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01611.x
,1998, 'Changes and chances', Australian and New Zealand Journal of Medicine, 28, pp. 415 - 416, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02072.x
,1998, 'XVI Scientific Meeting of the International Society of Hypertension, Glasgow, 23 June 1996: Introduction', Journal of Hypertension, Supplement, 16
,1998, 'Development of a new assay for measurement of total angiotensin-converting enzyme after inhibition', Clinical and Experimental Pharmacology and Physiology
,1997, 'Drug-induced hypotension in the elderly patient', Current Therapeutics, 38, pp. 59 - 63
,1997, 'Immune reactivity for nitric oxide synthase and endothelin in the coronary and basilar arteries of renal hypertensive rats', Cell and Tissue Research, pp. 509 - 516
,1997, 'Organ donation: How can we improve the rates?', Medical Journal of Australia, 166, pp. 622 - 623
,1996, 'Do we need health departments?', Australian and New Zealand journal of medicine, 26, pp. 767 - 768, http://dx.doi.org/10.1111/j.1445-5994.1996.tb00621.x
,1996, 'Mechanisms of decreased pressor response to infused angiotensin II in the pregnant rat', Nephrology, 2, pp. 409 - 415, http://dx.doi.org/10.1111/j.1440-1797.1996.tb00122.x
,1996, 'Studies of glomerular protein content in the diabetic hypertensive rat: The effect of antihypertensive therapy', Nephrology, 2, pp. 39 - 44, http://dx.doi.org/10.1111/j.1440-1797.1996.tb00064.x
,1996, 'A study of angiotensin II Receptors after chronic inhibition of nitric oxide synthase in the spontaneously hypertensive rat', Clinical and Experimental Pharmacology and Physiology, pp. 441 - 443
,1996, 'Angiotensin II: a humoral mediator for the gastric sodium monitor', American Journal of Physiology, pp. F406 - F410
,1996, 'Magnesium prophylaxis for eclampsia', New England Journal of Medicine, pp. 1638 - 1639
,1995, 'Magnesium sulfate versus phenytoin for the prevention of eclampsia', New England Journal of Medicine, 333, pp. 1638 - 1639, http://dx.doi.org/10.1056/NEJM199512143332413
,1995, 'Can cadaveric organ donation rates be improved?', Anaesthesia and Intensive Care, 23, pp. 99 - 103, http://dx.doi.org/10.1177/0310057x9502300117
,1995, 'Effects of endopeptidase 24.11 inhibition on plasma and tissue concentrations of vasoactive intestinal peptide', Clinical Science, 89, pp. 267 - 271, http://dx.doi.org/10.1042/cs0890267
,1995, 'Obtaining consent for organ donation in nine NSW metropolitan hospitals', Anaesthesia and Intensive Care, 23, pp. 81 - 87, http://dx.doi.org/10.1177/0310057x9502300115
,1995, 'PARTICIPATION OF THE RENIN‐ANGIOTENSIN SYSTEM IN REGULATING THE EXCRETORY RESPONSE TO ACUTE SODIUM INGESTION', Clinical and Experimental Pharmacology and Physiology, 22, pp. 455 - 456, http://dx.doi.org/10.1111/j.1440-1681.1995.tb02042.x
,1995, 'The identification of potential cadaveric organ donors', Anaesthesia and Intensive Care, 23, pp. 75 - 80, http://dx.doi.org/10.1177/0310057x9502300114
,1995, 'The Journal in 1994', Australian and New Zealand Journal of Medicine, 25, pp. 1 - 2, http://dx.doi.org/10.1111/j.1445-5994.1995.tb00569.x
,1995, 'Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit', Acta Physiologica Scandinavica, 153, pp. 255 - 261, http://dx.doi.org/10.1111/j.1748-1716.1995.tb09861.x
,1994, 'Association of acute leukaemia with chlorambucil after renal transplantation', The Lancet, 343, pp. 1298 - 1299, http://dx.doi.org/10.1016/S0140-6736(94)92189-X
,1994, 'Accuracy of single concentration estimations of platelet angiotensin ii receptor number its usefulness in screening for pregnancy-induced hypertension', American Journal of Hypertension, 7, pp. 989 - 995, http://dx.doi.org/10.1093/ajh/7.11.989
,1994, 'Angiotensin-converting enzyme inhibitors', Medical Journal of Australia, 160, pp. 279 - 281, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125832.x
,1994, 'DIFFERENTIAL REGULATION OF UTERINE AND GLOMERULAR ANGIOTENSIN II RECEPTORS IN NORMAL AND HYPERTENSIVE PREGNANCY IN THE RAT', Clinical and Experimental Pharmacology and Physiology, 21, pp. 253 - 256, http://dx.doi.org/10.1111/j.1440-1681.1994.tb02508.x
,1994, 'EFFECT OF NEUTRAL ENDOPEPTIDASE ON PLASMA AND TISSUE CONCENTRATIONS OF VASO‐ACTIVE INTESTINAL PEPTIDE', Clinical and Experimental Pharmacology and Physiology, 21, pp. 307 - 309, http://dx.doi.org/10.1111/j.1440-1681.1994.tb02517.x
,1994, 'The Journal in 1993', Australian and New Zealand Journal of Medicine, 24, pp. 1 - 2, http://dx.doi.org/10.1111/j.1445-5994.1994.tb04415.x
,1993, 'The costs of costing.', Australian and New Zealand Journal of Medicine, 23, pp. 338
,1993, 'ABNORMALITY OF THE GLOMERULAR ANGIOTENSIN II RECEPTOR IN EXPERIMENTAL DIABETIC NEPHROPATHY', Clinical and Experimental Pharmacology and Physiology, 20, pp. 348 - 350, http://dx.doi.org/10.1111/j.1440-1681.1993.tb01702.x
,1993, 'METABOLIC STUDIES OF URIDINE IN RATS WITH DOCA‐SALT HYPERTENSION AND ON HIGH SODIUM DIET', Clinical and Experimental Pharmacology and Physiology, 20, pp. 384 - 387, http://dx.doi.org/10.1111/j.1440-1681.1993.tb01712.x
,